Gesture control robotics replaces traditional buttons and joysticks with natural hand movements. This approach improves user ...

Qualcomm and Arduino unleash VENTUNO Q that lets AI move offline ...

In brief: A few months after acquiring Arduino, Qualcomm is introducing its first product designed to combine its processor technology with the "maker" ethos of the Italian company. Unsurprisingly, ...

There have been many questions about what direction Arduino would take after being bought by Qualcomm. Now it would seem that we’re getting a clearer picture. Perhaps unsurprisingly the answer appears ...

Five months after acquiring Arduino, the open-source hardware and software company best known for its UNO and Nano microcontroller board for hobbyists, Qualcomm is looking to make another big splash ...

Qualcomm, which purchased microcontroller board manufacturer Arduino last year, just announced a new single-board computer that marries AI with robotics. Called the Arduino Ventuno Q, it uses Qualcomm ...

Last year, Qualcomm acquired Arduino, a company known for its tinker-friendly microcontroller kits and single board computers (SBC). The first product to follow was the Uno Q, which was powerful ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...